Description

(2S,3R)-2-[[(2S)-6-Amino-2-[[(2S)-2-[[(2S)-2-Amino-3-Phenyl-Propanoyl] Amino]-3-(1H-Indol-3-Yl)Propanoyl]Amino]Hexanoyl]Amino]-3-Hydroxy-Buta Noic Acid is a complex, high-purity peptide derivative of significant interest in advanced pharmaceutical research and development. Its intricate structure, featuring multiple chiral centers and functional groups, makes it a critical building block for synthesizing novel bioactive compounds. This product is essential for researchers and manufacturers in the pharmaceutical, biotechnology, and fine chemical sectors who require precise, high-quality intermediates for drug discovery and process development.

Application

• Pharmaceutical Intermediate: Serves as a key chiral synthon in the research and development of new therapeutic peptides and peptidomimetics.
• Drug Discovery: Used as a building block in combinatorial chemistry and high-throughput screening libraries to identify new lead compounds.
• Bioconjugation: Acts as a specialized linker or spacer molecule in the synthesis of antibody-drug conjugates (ADCs) and other targeted therapies.
• Biochemical Research: Employed as a substrate or inhibitor in enzymatic studies and proteomics research due to its specific amino acid sequence.
• Fine Chemical Synthesis: Utilized in the multi-step synthesis of complex natural products and specialized organic molecules.
• Reference Standard: Provides a high-purity standard for analytical method development and quality control in pharmaceutical manufacturing.

Basic Information

Item	Detail
Product Name	(2S,3R)-2-[[(2S)-6-Amino-2-[[(2S)-2-[[(2S)-2-Amino-3-Phenyl-Propanoyl] Amino]-3-(1H-Indol-3-Yl)Propanoyl]Amino]Hexanoyl]Amino]-3-Hydroxy-Buta Noic Acid
CAS No.	91853-94-0
Molecular Formula	C32H44N6O7
Molecular Weight	624.73 g/mol
Synonyms	Fmoc-Lys(Boc)-Trp-Phe-Thr-OH; Nα-Fmoc-Nε-Boc-L-tryptophyl-L-phenylalanyl-L-threonine; Fmoc-Lys(Boc)-Trp-Phe-Thr; Tetrapeptide Fmoc-Lys(Boc)-Trp-Phe-Thr; Boc-Lys(Fmoc)-Trp-Phe-Thr; (2S,3R)-2-[[(2S)-6-[[(1,1-Dimethylethoxy)carbonyl]amino]-2-[[(2S)-2-[[(2S)-2-amino-3-phenyl-1-oxopropyl]amino]-3-(1H-indol-3-yl)-1-oxopropyl]amino]-1-oxohexyl]amino]-3-hydroxybutanoic acid; 9H-Fluoren-9-ylmethyl (2S)-6-[[(1,1-dimethylethoxy)carbonyl]amino]-2-[[(2S)-2-[[(2S)-2-amino-3-phenyl-propanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]hexanoyl-L-threoninate
EINECS	Contact for details

Quality Control

Our (2S,3R)-2-[[(2S)-6-Amino-2-[[(2S)-2-[[(2S)-2-Amino-3-Phenyl-Propanoyl] Amino]-3-(1H-Indol-3-Yl)Propanoyl]Amino]Hexanoyl]Amino]-3-Hydroxy-Buta Noic Acid is manufactured under strict quality management systems. Each batch undergoes comprehensive analytical testing, including HPLC for purity and chiral integrity, to ensure it meets the exacting standards required for pharmaceutical R&D. Certificates of Analysis (COA) with full traceability are provided, confirming compliance with specified parameters. We support cGMP and ISO guidelines for advanced intermediates.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). This product is hygroscopic (moisture-sensitive) and should be handled in a dry environment to prevent degradation. For long-term storage, consider desiccated conditions.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 98.0%
Chiral Purity	≥ 99.0%
Water Content (KF)	≤ 1.0%
Residue on Ignition	≤ 0.5%
Heavy Metals	≤ 20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.